PAHGF yields 7.76% · JNJ yields 2.13%● Live data
📍 PAHGF pulled ahead of the other in Year 1
Combined, PAHGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PAHGF + JNJ for your $10,000?
Pets at Home Group Plc engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom. It operates through three segments: Retail, Vet Group, and Central. The company offers a range of pet foods for dogs, cats, small animals, fish, reptiles, and birds. It also provides pet accessories, including cat litters, collars, leads and harnesses, bedding, housing, feeding, health and hygiene, travel, training, and enrichment products. In addition, the company offers pet grooming services comprising a full groom, bath and brush, microchipping, and nail clipping; and pet insurance products. Further, it operates First Opinion veterinary practices that provides pet healthcare advice services; and provides veterinary telehealth services. The company operates through 452 stores, 441 practices, and 316 grooming salons. It also provides products and services through online. Pets at Home Group Plc was founded in 1991 and is based in Handforth, the United Kingdom.
Full PAHGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.